Abeona Therapeutics Inc. (Nasdaq: ABEO) has recently become a member of the Rare Disease Company Coalition (RDCC), a coalition consisting of life science companies that are committed to developing therapies for rare diseases. Vish Seshadri, the CEO of Abeona, has also been appointed to the RDCC's Board of Directors. Abeona is thrilled to join forces with the RDCC and shares their dedication to a..
Neural Therapeutics Inc. (Neural), a company specializing in the discovery and development of ethnobotanical drugs, has successfully completed its rights offering. The offering came to an end on July 7, 2023, resulting in the issuance of 5,595,992 common shares at a price of $0.03 per share. This generated a total of approximately $167,880 in gross proceeds for Neural. The funds raised from the ..
Catalent, a healthcare product technology provider, has finally released its Q3 financial report for fiscal 2023 after delays in May. The company's revenue of $1.04 billion beat Wall Street projections despite being 19% below last year's Q3 revenue. However, the company reported an adjusted net loss of $17 million due to operational challenges and unexpected cost increases at some manufacturing ..
Illumina CEO Francis deSouza has resigned from his position, effective immediately. The announcement comes after activist investor Carl Icahn attempted to place three representatives on Illumina's board ahead of the annual shareholder meeting last month. Icahn criticized deSouza's leadership and the incumbent board's failure to maximize value for shareholders, specifically pointing to the 2020 a..
